Malignant pleural mesothelioma: current treatments and emerging drugs

Author： Belli Carmen   Fennell Dean   Giovannini Monica   Gaudino Giovanni   Mutti Luciano  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.14, Iss.3, 2009-09, pp. : 423-437

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current chemotherapeutic treatment of malignant pleural mesothelioma

By Nowak Anna K   Byrne Michael J   Millward Michael J   Alvarez John M   Robinson Bruce WS  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 12, 2004-12 ,pp. : 2441-2449

Informa Healthcare

Access to resources Recommend Favorite

Pemetrexed/cisplatin worth it in malignant pleural mesothelioma

By  

Inpharma, Vol. 1, Iss. 1627, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Raltitrexed + cisplatin beneficial for malignant pleural mesothelioma

By  

Inpharma, Vol. 1, Iss. 1512, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Pemetrexed + cisplatin: first-line for malignant pleural mesothelioma

By  

Inpharma, Vol. 1, Iss. 1404, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Anti-angiogenic therapies for malignant pleural mesothelioma

By Ceresoli Giovanni Luca   Zucali Paolo Andrea  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 6, 2012-06 ,pp. : 833-844

Informa Healthcare

Access to resources Recommend Favorite